United States · FDA National Drug Code directory
Clopidogrel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-414_360ed8dd-4f92-46fc-b31b-abe0d75e9bb3
- Product NDC
- 65162-414
- Form
- TABLET
- Composition / generic term
- Clopidogrel
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130930
- Source listing expiry
- 20261231
Source-listed ingredients
- CLOPIDOGREL BISULFATE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (65162-414-03) · 65162-414-03
- 90 TABLET in 1 BOTTLE (65162-414-09) · 65162-414-09
- 1000 TABLET in 1 BOTTLE (65162-414-11) · 65162-414-11
- 500 TABLET in 1 BOTTLE (65162-414-50) · 65162-414-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →